PRA Health Sciences (acquired by ICON)
At PRA Health Sciences, providing innovative solutions for our clients is what we do. Side-by-side with our clients, we strive to move drug discovery forward, helping them to develop life-saving and life-improving drugs. PRA has more than 10,000 employees working in 80+ countries providing comprehensive clinical development services across all phases. From full service clinical development to the pioneering Embedded Solutions™ model, PRA provides a broad spectrum of solutions that meet the demands of a diverse marketplace. As a top five CRO, we have worked on 100+ marketed drugs across several therapeutic areas and conducted the pivotal or supportive trials that led to FDA and/or international regulatory approval of 45+ such drugs.
Specialties: Clinical Research, Phase I-IIa, Phase II-III, Post Approval, Safety & Risk Management, Therapeutic Expertise, Biosimilars, Bioanalytical Laboratories, Rare Disease, Oncology, Immunology, Infectious Disease, Neuroscience, Pain, Pediatrics, Vaccines, Data & Techology Solutions, Early Development Services, Laboratory Solutions, Real World Solutions, Clinical Development, Product Registration, Respiratory, and Cardio-metabolic
Label: pharma R&D outsourcing